Randomized phase II study of nintedanib with or without pirfenidone in patients with idiopathic pulmonary fibrosis who experienced disease progression during prior pirfenidone admi... by Satoshi Ikeda, MD, PhD, Akimasa Sekine, MD, PhD, Tomohisa Baba, MD, Terufumi Kato, MD, Takuma Katano, MD, Erina Tabata, MD, Ryota Shintani, MD, Hideaki Yamakawa, MD, PhD, Tsuneyuki Oda, MD, PhD, Ryo Okuda, MD, Hideya Kitamura, MD, PhD, Tae Iwasawa, MD, PhD, Tamiko Takemura, MD, PhD, Takashi Ogura, MD, Jorddy Neves Cruz.

Get full text